CN106962912A - A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof - Google Patents
A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN106962912A CN106962912A CN201710198915.1A CN201710198915A CN106962912A CN 106962912 A CN106962912 A CN 106962912A CN 201710198915 A CN201710198915 A CN 201710198915A CN 106962912 A CN106962912 A CN 106962912A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- hepatopathy
- drinking
- integration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 44
- 208000019423 liver disease Diseases 0.000 title claims abstract description 40
- 230000035764 nutrition Effects 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000009472 formulation Methods 0.000 title abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 109
- 229940088594 vitamin Drugs 0.000 claims abstract description 51
- 229930003231 vitamin Natural products 0.000 claims abstract description 51
- 235000013343 vitamin Nutrition 0.000 claims abstract description 51
- 239000011782 vitamin Substances 0.000 claims abstract description 51
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 51
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 34
- 235000013305 food Nutrition 0.000 claims abstract description 33
- 230000035622 drinking Effects 0.000 claims abstract description 26
- 235000008216 herbs Nutrition 0.000 claims abstract description 25
- 230000010354 integration Effects 0.000 claims abstract description 25
- 235000012054 meals Nutrition 0.000 claims abstract description 25
- 235000015097 nutrients Nutrition 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 241000196324 Embryophyta Species 0.000 claims abstract description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 16
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 16
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 16
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 16
- 150000004676 glycans Chemical class 0.000 claims abstract description 16
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 16
- 239000005017 polysaccharide Substances 0.000 claims abstract description 16
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- 239000011573 trace mineral Substances 0.000 claims abstract description 14
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 13
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 11
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 11
- 240000004307 Citrus medica Species 0.000 claims abstract description 11
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 11
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 11
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 11
- 241000218231 Moraceae Species 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 11
- 244000189799 Asimina triloba Species 0.000 claims abstract description 9
- 238000001694 spray drying Methods 0.000 claims abstract description 3
- 238000003809 water extraction Methods 0.000 claims abstract description 3
- 235000019197 fats Nutrition 0.000 claims description 21
- 235000018102 proteins Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000014633 carbohydrates Nutrition 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 241000206575 Chondrus crispus Species 0.000 claims description 8
- 235000010489 acacia gum Nutrition 0.000 claims description 7
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 235000010419 agar Nutrition 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000003132 food thickener Nutrition 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 3
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 3
- 229920002581 Glucomannan Polymers 0.000 claims description 3
- 229920002907 Guar gum Polymers 0.000 claims description 3
- 229920000161 Locust bean gum Polymers 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 229940046240 glucomannan Drugs 0.000 claims description 3
- 239000000665 guar gum Substances 0.000 claims description 3
- 235000010417 guar gum Nutrition 0.000 claims description 3
- 229960002154 guar gum Drugs 0.000 claims description 3
- 239000000252 konjac Substances 0.000 claims description 3
- 235000010485 konjac Nutrition 0.000 claims description 3
- 235000010420 locust bean gum Nutrition 0.000 claims description 3
- 239000000711 locust bean gum Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 claims 1
- 239000011805 ball Substances 0.000 claims 1
- 210000005229 liver cell Anatomy 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 238000012216 screening Methods 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 3
- 235000013350 formula milk Nutrition 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- -1 lard Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 235000010469 Glycine max Nutrition 0.000 description 11
- 231100000753 hepatic injury Toxicity 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 229920002774 Maltodextrin Polymers 0.000 description 9
- 239000005913 Maltodextrin Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 229940035034 maltodextrin Drugs 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 229920001202 Inulin Polymers 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 8
- 239000005862 Whey Substances 0.000 description 8
- 108010046377 Whey Proteins Proteins 0.000 description 8
- 102000007544 Whey Proteins Human genes 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 8
- 229940029339 inulin Drugs 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 7
- 206010067125 Liver injury Diseases 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000008101 lactose Substances 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 241000972773 Aulopiformes Species 0.000 description 6
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 6
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 6
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 6
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 6
- 244000077995 Coix lacryma jobi Species 0.000 description 6
- 244000000626 Daucus carota Species 0.000 description 6
- 235000002767 Daucus carota Nutrition 0.000 description 6
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 6
- 240000008620 Fagopyrum esculentum Species 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 235000011453 Vigna umbellata Nutrition 0.000 description 6
- 240000001417 Vigna umbellata Species 0.000 description 6
- 235000015278 beef Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 235000019515 salmon Nutrition 0.000 description 6
- 235000019710 soybean protein Nutrition 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 235000004347 Perilla Nutrition 0.000 description 5
- 244000124853 Perilla frutescens Species 0.000 description 5
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 5
- 244000046052 Phaseolus vulgaris Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 235000008390 olive oil Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000003549 soybean oil Substances 0.000 description 5
- 235000012424 soybean oil Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 4
- 240000003183 Manihot esculenta Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 235000021277 colostrum Nutrition 0.000 description 4
- 210000003022 colostrum Anatomy 0.000 description 4
- 239000011162 core material Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- 229960003512 nicotinic acid Drugs 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229960003080 taurine Drugs 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 239000011716 vitamin B2 Substances 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000219112 Cucumis Species 0.000 description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229960005069 calcium Drugs 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229940091250 magnesium supplement Drugs 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 240000006432 Carica papaya Species 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010057573 Chronic hepatic failure Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 208000010334 End Stage Liver Disease Diseases 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 240000001740 Momordica dioica Species 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 102000015094 Paraproteins Human genes 0.000 description 1
- 108010064255 Paraproteins Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001300674 Plukenetia volubilis Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- 208000011444 chronic liver failure Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000020243 first infant milk formula Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Substances [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 150000007949 saponins Chemical group 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof, including protein, fat, carbohydrate, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and new resource food;Wherein, new resource food includes swan-mussel polysaccharide, and integration of drinking and medicinal herbs composition includes peppermint, Poria cocos, matrimony vine, pawpaw, Chinese yam, mulberries, spina date seed, citron;Its preparation method is:Each component is previously prepared into powder, is then well mixed and corresponding formulation is made;Wherein, integration of drinking and medicinal herbs composition carries out water extraction concentration, spray drying and powder is made, and vitamin and fat are handled by microencapsulation respectively is made powder.Screening and proportioning by said components; nutrient formulation of the present invention can be energy, critical nutrients and the essential trace element needed for hepatopath provides; under the synergy of each component, the treatment of hepatopathy and the protection of liver cell are carried out, slows down the disease development of hepatopathy.
Description
Technical field
The present invention relates to enteral nutrition preparation field, and in particular to a kind of hepatopathy tailored version clinical nutrition formula and its preparation
Method.
Background technology
Hepatopathy refers to the lesion for occurring in liver, is a kind of great disease of common harmfulness.Hepatopathy species is according to hair
Anttdisease Mechanism can be divided into viral liver disease and Non-viral liver disease.Viral liver disease is one as caused by a variety of different hepatitis viruses
Group with liver do harm to based on infectious disease, according to etiological diagnosis, hepatitis viruse at least 5 kinds, i.e. first, second, third, fourth, penta type liver
Scorching virus, causes first, second, third, fourth, viral hepatitis type E respectively;Non-viral liver disease includes following several:AML
It is due to the hepar damnification disease caused by long-term heavy drinking (being addicted to drink);Medicine or poisonous substance hepatopathy be by chemical toxicant (such as
Phosphorus, arsenic, carbon tetrachloride etc.), medicine or hepatitis or caused hepatic disease caused by biotoxin;Pathobolism liver
Disease is in vivo to the bad caused hepatopathy of certain material metabolism;Fatty liver disease refers to due to liver caused by a variety of causes
The excessive lesion of intracellular fat accumulation, causing the fat content of liver cell increases, and possible cause has excessive drinking, diabetes, blood fat
Fat is too high, overweight etc..
Liver is the maximum metabolic organ of human body, while being also one of most important internal organs in digestive system, it joins extensively
With internal complicated biochemical process, including carbohydrate, metabolism, the storage of vitamin and the activation of fat and protein etc.,
Removing toxic substances and generation metabolic waste etc..Liver will appear from complexity nutrient metabolic when ill changes, especially in End-stage liver disease or
In patient's body of liver failure, liver function, which is badly damaged, greatly affected body substance and energetic supersession, thus generally
Cause more serious malnutrition.Therefore, to liver diseases or dyshepatia patient, it should be changed according to disease event, metabolism
And nutrition condition, suitable energy substance and nutritional supportive path are selected, rational nutritional support is carried out.
With the development of food of special nutrients, according to the physilogical characteristics and nutritional need of hepatopath, for hepatopath
The special formulation food of exploitation is also increasing, and such as Chinese patent CN105942506A discloses a kind of suitable for hepatopath's
Special medicine purposes formula food, but it is not added with dietary fiber, meals elite, integration of drinking and medicinal herbs composition and new resource food, this
Cause it can not fully meet the nutritional need of hepatopath, it is alleviated and the effect for the treatment of hepatopathy is extremely limited;It is Chinese special
Sharp CN105361146A discloses the full nutrition special formulation food that a kind of hepatopath eats, but its medicine-food two-purpose for being used
Up to 31 kinds of Chinese herbal medicine extract, and it not using compositions such as meals elite, and the processing of each composition is relative complex, this causes
Its product cost is higher.
Therefore, be badly in need of that a kind of component is less but nutritional ingredient comprehensively and the price more cheap spy suitable for hepatopath
Different formula food.
The content of the invention
It is an object of the invention to overcoming defect of the prior art to be formulated there is provided a kind of hepatopathy tailored version clinical nutrition and
Its preparation method, hepatopathy tailored version clinical nutrition formula prepared by the present invention provides comprehensive nutritional support for hepatopath, its
Containing the suitable energy and various critical nutrients needed for hepatopath, there is provided complete required micro-nutrient composition;Pass through
Integration of drinking and medicinal herbs composition and new resource food of the addition containing a variety of functional active components, it can mitigate liver kidney burden, be effective against
Inflammation, killing virus, strengthens resistance of human body, also with clearing heat and detoxicating, regulating the function of the liver and spleen and prevents and treats the functions such as hepatopathy, nutrition
Each composition complements each other in formula, can effectively improve the malnutritive symptom of hepatopath, and conditioning engine body function, is conducive to liver
The anti-inflammatory liver protection of patient, and improve the life quality of patient and slow down disease development.
To achieve the above object, the present invention is adopted the following technical scheme that:
On the one hand, the present invention provides a kind of hepatopathy tailored version clinical nutrition formula, including following component:Protein, fat,
Carbohydrate, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants
Compound and new resource food;Wherein, the new resource food includes swan-mussel polysaccharide;Wherein, the integration of drinking and medicinal herbs composition includes
Peppermint, Poria cocos, matrimony vine, pawpaw, Chinese yam, mulberries, spina date seed, citron.
In order to further optimize above-mentioned technical proposal, the technical measures that the present invention is taken also include:
Preferably, the hepatopathy tailored version clinical nutrition formula, in addition to food thickening agent and food additives, the food
Product thickener be guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum at least
One kind, the food additives are at least one of Aspartame, flavoring essence spices, brown sugar.
Preferably, the vitamin is water soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin
Account for the 10%~40% of vitamin gross weight.
Preferably, the dietary fiber is water-soluble dietary fiber and insoluble dietary fiber, wherein the water-soluble meals
The weight of food fiber accounts for the 70%~75% of dietary fiber gross weight;
Preferably, the parts by weight of the component are:20~30 parts of protein, 5~15 parts of fat, carbohydrate 45~
55 parts, 2~8 parts of dietary fiber, 0.6~1.2 part of macroelement, 0.01-0.06 parts of trace element, vitamin 0.05~0.25
Part, 0.5~1.5 part of meals elite, 0.1~6 part of integration of drinking and medicinal herbs composition, 0.1-1 parts of natural plants compound and new resources food
0.01-0.1 parts of product.
Preferably, the parts by weight of each component are as follows in the integration of drinking and medicinal herbs composition:0~1 part of peppermint, 0~1 part of Poria cocos,
0~1 part of matrimony vine, 0~1 part of pawpaw, 0~1 part of Chinese yam, 0~1 part of mulberries, 0~1 part of spina date seed, 0~1 part of citron.
Preferably, the protein is selected from PURE WHEY, soybean protein isolate, whole milk powder, dried whole-egg, newborn iron egg
In vain, at least one of bovine colostrum, amino acid, protein peptides;Wherein, the amino acid is selected from 1B-Pidolidone, L-
In glutamic acid, L-arginine, L-Trp, Glu, taurine, Valine, ILE, L-Leu extremely
Few one kind;The protein peptides be selected from soybean oligopeptide, wheat protein peptide, pupa albumen peptide, ocean fish oligopeptide powder, laughable peptide,
At least one of amino peptide, ovalbumin peptide.
Preferably, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO structures
At least one of fat, DHA, EPA, ARA, phosphatide, more specifically it is described fat include safflower seed oil, walnut oil, peanut oil,
Soybean oil, Ah's glycerine, olive oil, tea oil, oil and fat of sacha inchi, coconut oil, perilla herb oil, deep sea fish oil, cupu oil, palm oil, butter,
Cream, lard, medium chain triglyceride, lecithin, single diglycerine fatty acid ester.
Preferably, the carbohydrate is included in fructose, rock sugar, lactose, maltodextrin, tapioca, resistant starch
At least two.
Preferably, the dietary fiber comprising inulin, konjaku flour, galactooligosaccharide, FOS, oligoisomaltose,
At least one of soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber.
Preferably, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, K-IAO, sodium citrate
At least one of with magnesium gluconate.
Preferably, the trace element is selected from ferrous gluconate, KI, zinc gluconate, sodium selenite, glucose
At least one of sour copper, chromium sulfate, manganese gluconate and sodium molybdate.
Preferably, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, vitamin K1
At least one of.
Preferably, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin
At least one of C, pantothenic acid, folic acid, nicotinic acid, choline, inositol, biotin.
Preferably, the meals elite is selected from cereal, beans, potato class, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;Wherein described cereal it is main by rice meal, millet powder, black rice flour, coixlacrymajobi powder,
One kind in corn flour, wheat germ powder, oatmeal, buckwheat or at least two compositions, the beans it is main by peameal, it is green
One kind or at least two compositions in bean powder, black bean powder, red bean powder, soy meal, the potato class is mainly made up of common yam rhizome powder, described
Vegetable powder is main by one in carrot meal, white radish powder, pumpkin powder, spinach powder, tomato meal, broccoli powder, balsam pear powder, cucumber powder
Plant or several compositions, the Homonemeae is main by the one or more in mushroom powder and white fungus powder, and the nut-seed class is main
It is lotus nut starch, the fish and shrimp are mainly made up of the one or more in salmon powder and cod meal, the poultry meat master
If being made up of the one or more in chicken meal, powdered beef, the fruits are main by red date powder, longan powder, apple powder, cherry
One or more of compositions in peach powder, citrus powder, pyrus nivalis powder;It is the preferred coixlacrymajobi powder of meals elite, oatmeal, buckwheat, red
Bean powder, carrot meal, broccoli powder, white fungus powder, salmon powder, powdered beef, red date powder.
Preferably, the natural plants compound is selected from l-cn, Glucosamine, FOS, lutein, plant
At least one of sterol, lycopene, resveratrol, allicin;The natural plants compound is preferably l-cn.
Preferably, the new resource food is selected from first milk basic protein, γ-aminobutyric acid, chitosan oligosaccharide, eucommia Bark male flower, freshwater mussel
In meat polysaccharide, bamboo-leaves flavones, CPP, avenabeta glucosan, yeast beta-dextran, leaf of Moringa, xylo-oligosaccharide extremely
Few one kind;The new resource food is preferably swan-mussel polysaccharide.
On the other hand, the present invention relates to a kind of preparation method of above-mentioned hepatopathy tailored version clinical nutrition formula, including it is as follows
Step:
Step 1: by the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, micro
It is 150~250 that element, vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food are prepared into particle diameter respectively
μm powder;
It is well mixed Step 2: powder prepared by the step one is poured into cone-type mixer successively;
Step 3: using the step one be well mixed powder be prepared into nutrient powder, nutrition emulsion, capsule, tablet,
At least one of pill or oral liquid;
Wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, water extraction is concentrated, and concentrate is carried out into spray drying system
Into integration of drinking and medicinal herbs component powders;
Wherein, the vitamin and fat are handled by microencapsulation respectively is prepared into vitamin powder and fat powder.
Preferably, the preparation process of the integration of drinking and medicinal herbs component powders is as follows:Using pulverizer to predetermined weight number
Raw material is crushed, and the raw material of crushing is placed in container, is added 3~8 times of the water that weight is raw material weight, is carried out immersion 3
~4 hours, then soak is carried out to decoct 30~60min, filtering removes raw material, leaves and takes decoction liquor, spray decoction liquor
Mist drying prepares integration of drinking and medicinal herbs component powders.
Preferably, what the microencapsulation of the vitamin was handled comprises the following steps that:1) it regard liposoluble vitamin as core
Material, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer are as wall material, high-pressure homogeneous emulsification, and spraying is instantaneous to be dried, and screening prepares liposoluble
Property vitamin powder;2) using water soluble vitamin as core, from sodium carboxymethylcellulose, gelatin, carragheen, xanthans,
Arabic gum, maltodextrin, lipoprotein, corn syrup, soybean protein isolate, whole-fat milk powder, dietary fiber, inulin, whey egg
One or more in white powder, oligoisomaltose, soybean fiber, lactose, candy sugar powder, emulsifying agent, stabilizer are mixed as wall material
Close uniform, spraying is instantaneous to be dried, and screening prepares water soluble vitamin powder.
Preferably, the specific implementation step of the fatty micro-capsule embedding techniques is as follows:By fat, emulsifying agent, wall material with
Water mixed dissolution prepares emulsion;After the stirring mixing of above-mentioned emulsion, emulsifying homogeneous processing is carried out, spraying is then carried out dry
Dry, screening prepares powdered oil, and powdered oil is compared with conventional grease, and its dispersiveness, water solubility, emulsibility, inoxidizability are all
Improve a lot;Wherein, the emulsifying agent be selected from fatty acid glyceride (glyceride), methyl glycol fatty acid ester (propylene glycol ester),
One or more in sorbitan aliphatic ester (sorbitan acid), sucrose fatty ester (sucrose ester), lecithin;The wall
Material is selected from sodium carboxymethylcellulose, gelatin, carragheen, xanthans, Arabic gum, maltodextrin, lipoprotein, corn syrup, big
Beans protein isolate, whole-fat milk powder, dietary fiber, inulin, PURE WHEY, oligoisomaltose, soybean fiber, lactose, rock sugar
One or more in powder, emulsifying agent, stabilizer.
The present invention using have anti-inflammatory protect liver, the integration of drinking and medicinal herbs composition of strengthen immunity, it include peppermint, Poria cocos, matrimony vine,
Pawpaw, Chinese yam, mulberries, spina date seed, citron.
Mint extract sample has significant protective effect to D-Gal induced mice acute liver damage, and peppermint carries
Take thing sample to dramatically increase rat bile secretory volume, there is obvious choleretic effect to rat.
Poria cocos can strengthen body's immunity, and pachymaran has obvious antitumor action;There is diuresis, urine can be increased
The discharge of the electrolyte such as middle potassium, sodium, chlorine;There are the effects such as calm and protection liver, the generation, the hypoglycemic, anti-radiation that suppress ulcer.
LBP-X has repair to hepatic injury caused by carbon tetrachloride in matrimony vine, and its mechanism may be by prevention
The damage of matter net, promotes protein synthesis and detoxication, recovers the function of liver cell, and promote liver cell regeneration;Matrimony vine is thick
Polysaccharide can reduce hepatic tissue mda content, and carbon tetrachloride hepatic injury mouse liver glycogen content can be made significantly to raise, and improve human body
Energy reserve;The active ingredient in matrimony vine can improve mitochondrial form to alcoholic liver disease of rats model, mitigate liver simultaneously
The steatosis and inflammation degree of necrosis of cell.
Contain multiple beneficial composition, including pawpaw polysaccharide, papain, oleanolic acid, phytosterin compound in pawpaw
Deng;Pawpaw polysaccharide has anticoagulation, suppression infection, imperial radiation, antitumor, anti-inflammatory, antiviral, the anti-ageing effect of waiting for a long time, and is preferable
Immunopotentiator;Papain can decomposing protein, have auxiliary treatment enterogastritis, indigestion, pawpaw contains a variety of water
Soluble vitamin, is such as rich in vitamin C, helps to repair body tissue, eliminates the noxious material of infringement body cell, strengthens people
Body resistance against diseases;Oleanolic acid exists with monomer or saponin form, internal with anti-inflammatory, strengthen immunity, transaminase lowering, correction
Paraprotein is metabolized, prevents hepatic sclerosis;Phytosterin compound, has stronger antiinflammatory action to human body, can promote wound healing,
Make hypertrophy, enhancing capillary circulation.
Chinese yam especially Chinese yam polysaccharide has good immunoregulation effect, and the phosphatide constituents of Chinese yam, which have, improves immune
The effect of function, Chinese yam is that Chinese medicine is adjusted in tonifying middle-Jiao and Qi, has good adjustment effect to digestion function, Chinese yam can also increase
Strong Small Intestinal, suppressing the allantoin in the secretion of serum amylase, Chinese yam has anti-irritant, analgesia, anti-inflammatory suppression
Bacterium etc. acts on.
Active ingredient mulberry polysaccharide in mulberries can be remarkably decreased the Th2 cytohormones secreted by spleen cell, blood processed
Clear IgG1 generation, reduces the secretion of abdominal cavity cell TNF-α, and the effect with anti-inflammatory slows down allergic immune response.
Spina date seed aqueous extract has obvious antiinflammatory action, can suppress mouse peritoneal, skin of back and auricle blood capillary
Pipe permeability, has inhibitory action to the granuloma that the swelling of rat hindleg egg white and the rat oxter implantation scraps of paper are produced, has
Effect of strengthen immunity.
Volatile oil contained by citron has gentle stimulation to intestines and stomach, can promote to wriggle and digestive juice secretion in stomach, row
Except enteral pneumatosis, and there are phlegm-dispelling functions;Hesperidine contained by fragrant pavilion has anti-inflammatory, an antivirus action, and with prevention frostbite and
Suppress the aldehyde reductase effect of rat lens;Obakunone contained by fragrant pavilion plays the role of enhancing isolated rabbit intestines tension force and amplitude.
The present invention also uses new resource food, including swan-mussel polysaccharide, and swan-mussel polysaccharide can improve hepatocyte viability and peroxide
Compound is disproportionated enzyme activity, and it has direct protective action to liver cell, and it can significantly increase index and spleen index, thymus index
Deng with certain vivo immunization humidification.
The present invention also uses meals elite, including coixlacrymajobi powder, oatmeal, buckwheat, red bean powder, carrot meal, broccoli
Powder, white fungus powder, salmon powder, powdered beef, red date powder, its comprehensive nutrition are more beneficial for the physical recovery and stomach of hepatopath
Conditioning.
Compared with prior art, the present invention has following excellent effect:
(1) modern nutriology achievement in research is combined by the present invention with Traditional Chinese medical theory, passes through the organic of various components
Combination, various functions is merged, and pass through the synergy between active ingredient, humidification effect.Match somebody with somebody by the present invention
The food that side makes can not only supplement nutrition needed for hepatopath, moreover it is possible to promote body condition to improve using medicinal herb componentses.
(2) inventive formulation food is using the peppermint in integration of drinking and medicinal herbs composition, Poria cocos, matrimony vine, pawpaw, Chinese yam, mulberries, acid
Jujube kernel, citron, it, which has, improves the effects such as immunity, anti-inflammatory protect liver, antiviral, dampness removing invigorating the spleen;It is easy using amino acid and polypeptide
In absorption, immunity of organisms can be improved;Using natural plants compound l-cn, to supplement because carnitine is sought caused by hepatopathy
Support and lack, maintain the normal function of body;Using new resource food swan-mussel polysaccharide, liver cell is further protected;In said components
Synergy under, can be comprehensively quickly nutrient necessary to hepatopath, while the treatment of positive carry out hepatopathy
And the protection of liver cell, improve the life quality of patient and slow down disease progression.
(3) present invention prepares vitamin using micro-capsule embedding techniques, and vitamin is embedded in wall material, can prevent dimension from giving birth to
Element is destroyed by macroelement, trace element, extends the holding time of vitamin;The present invention is prepared using micro-capsule embedding techniques
Powdered oil so that powdered oil has preferable mobility, it is easy to be well mixed with other powdered components;And use micro-capsule bag
Bury after technology, grease is embedded in wall material, so that the contact with air is avoided to strengthen inoxidizability, so as to play guarantor
The maximum effect of strong type grease.
(4) raw material of hepatopathy tailored version clinical nutrition of the present invention formula in preparation process it is previously prepared into
150~250 μm of powder, this make it that, when preparing finished product, each nutrition composition can be well mixed, it is ensured that each in unit volume
The content of nutrition composition is identical, while when preparing liquid type preparation, each nutrition composition can be fully dispersed and is completely dissolved to molten
In agent, prevent occurring solid precipitation in liquid, effect of finished product product has been effectively ensured.
Embodiment
The present invention provides a kind of for hepatopathy tailored version clinical nutrition formula tailored version clinical nutrition formula, including following weight
Measure the component of number:20~30 parts of protein, fat 5~15 parts, 45~55 parts of carbohydrate, 2~8 parts of dietary fiber, often
0.6~1.2 part of secondary element, 0.01-0.06 parts of trace element, 0.05~0.25 part of vitamin, 0.5~1.5 part of meals elite, medicine
Food is with 0.01-0.1 parts of 0.1~6 part of derived components, 0.1-1 parts of natural plants compound and new resource food;Wherein, the dimension
Raw element is water soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin account for vitamin gross weight 10%~
40%;Wherein, the dietary fiber is water-soluble dietary fiber and insoluble dietary fiber, wherein the water-soluble dietary fiber
Weight account for the 70%~75% of dietary fiber gross weight.
With reference to embodiment, the embodiment to the present invention is further described.Following examples are only used for more
Plus technical scheme is clearly demonstrated, and can not be limited the scope of the invention with this.
Embodiment 1
Hepatopathy tailored version clinical nutrition formula of the present invention includes PURE WHEY 14.64g, soybean protein isolate
8.18g, whole milk powder 10g, dried whole-egg 0.18g, bovine colostrum 0.1g, taurine 0.12g, soy oligosaccharides Gly-His-Lys 0.1g, ocean
Fish oligopeptide powder 0.1g;Olive oil 0.39g, soybean oil 0.63g, coconut oil 0.39g, perilla herb oil 0.27g, medium chain triglyceride
3.03g, single diglycerine fatty acid ester 0.09g;Maltodextrin 33.4g, tapioca 11.63g;Resistant dextrin 2.7g, oligomeric half
Lactose 0.54g, inulin 0.9g, oligoisomaltose 0.91g;Calcium 0.15g, phosphorus 0.256g, potassium 0.093g, sodium in macroelement
0.177g, magnesium 0.177g;Iron 0.011g, zinc 0.007g in trace element;Vitamin A 0.004g, beta carotene 0.017g, dimension
Raw element D30.0005g, vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B6 0.001g、
Vitamin B120.00013g, vitamin C 0.127g, pantothenic acid 0.003g, folic acid 0.00017g, nicotinic acid 0.0133g;Coixlacrymajobi powder
0.09g, oatmeal 0.09g, buckwheat 0.09g, red bean powder 0.09g, carrot meal 0.09g, broccoli powder 0.09g, white fungus powder
0.09g, salmon powder 0.09g, powdered beef 0.09g, red date powder 0.09g;Peppermint 0.05g, Poria cocos 0.05g, matrimony vine 0.05g, wood
Melon 0.05g, Chinese yam 0.05g, mulberries 0.05g, spina date seed 0.05g, citron 0.03g;L-cn in natural plants compound
0.5g;Swan-mussel polysaccharide 0.01g in new resource food;Wherein, the weight of the water-soluble dietary fiber accounts for dietary fiber gross weight
70%~75%;The weight of the liposoluble vitamin accounts for the 10%~40% of vitamin gross weight;The protein is accounted for always
Energy 20~30%, fat accounts for the 10~25% of gross energy, carbohydrate and accounts for the 50~60% of gross energy.
Embodiment 2
Hepatopathy tailored version clinical nutrition formula of the present invention includes PURE WHEY 14.64g, soybean protein isolate
8.18g, whole milk powder 10g, dried whole-egg 0.18g, bovine colostrum 0.1g, taurine 0.12g, soy oligosaccharides Gly-His-Lys 0.1g, ocean
Fish oligopeptide powder 0.1g;Olive oil 0.39g, soybean oil 0.63g, coconut oil 0.39g, perilla herb oil 0.27g, medium chain triglyceride
3.03g, single diglycerine fatty acid ester 0.09g;Maltodextrin 33.4g, tapioca 11.63g;Resistant dextrin 2.7g, oligomeric half
Lactose 0.54g, inulin 0.9g, oligoisomaltose 0.91g;Calcium 0.15g, phosphorus 0.256g, potassium 0.093g, sodium in macroelement
0.177g, magnesium 0.177g;Iron 0.011g, zinc 0.007g in trace element;Vitamin A 0.004g, beta carotene 0.017g, dimension
Raw element D30.0005g, vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B6 0.001g、
Vitamin B120.00013g, vitamin C 0.127g, pantothenic acid 0.003g, folic acid 0.00017g, nicotinic acid 0.0133g;Coixlacrymajobi powder
0.09g, oatmeal 0.09g, buckwheat 0.09g, red bean powder 0.09g, carrot meal 0.09g, broccoli powder 0.09g, white fungus powder
0.09g, salmon powder 0.09g, powdered beef 0.09g, red date powder 0.09g;Peppermint 0.09g, Poria cocos 0.09g, matrimony vine 0.09g, wood
Melon 0.09g, Chinese yam 0.09g, mulberries 0.09g, spina date seed 0.09g, citron 0.07g;L-cn in natural plants compound
0.64g;Swan-mussel polysaccharide 0.02g in new resource food;Wherein, the weight of the water-soluble dietary fiber accounts for dietary fiber gross weight
70%~75%;The weight of the liposoluble vitamin accounts for the 10%~40% of vitamin gross weight;The protein is accounted for always
Energy 20~30%, fat accounts for the 10~25% of gross energy, carbohydrate and accounts for the 50~60% of gross energy.
Embodiment 3
Hepatopathy tailored version clinical nutrition formula of the present invention includes PURE WHEY 14.64g, soybean protein isolate
8.18g, whole milk powder 10g, dried whole-egg 0.18g, bovine colostrum 0.1g, taurine 0.12g, soy oligosaccharides Gly-His-Lys 0.1g, ocean
Fish oligopeptide powder 0.1g;Olive oil 0.39g, soybean oil 0.63g, coconut oil 0.39g, perilla herb oil 0.27g, medium chain triglyceride
3.03g, single diglycerine fatty acid ester 0.09g;Maltodextrin 33.4g, tapioca 11.63g;Resistant dextrin 2.7g, oligomeric half
Lactose 0.54g, inulin 0.9g, oligoisomaltose 0.91g;Calcium 0.15g, phosphorus 0.256g, potassium 0.093g, sodium in macroelement
0.177g, magnesium 0.177g;Iron 0.011g, zinc 0.007g in trace element;Vitamin A 0.004g, beta carotene 0.017g, dimension
Raw element D30.0005g, vitamin E 0.009g;Vitamin B10.001g, vitamin B20.001g, vitamin B6 0.001g、
Vitamin B120.00013g, vitamin C 0.127g, pantothenic acid 0.003g, folic acid 0.00017g, nicotinic acid 0.0133g;Coixlacrymajobi powder
0.09g, oatmeal 0.09g, buckwheat 0.09g, red bean powder 0.09g, carrot meal 0.09g, broccoli powder 0.09g, white fungus powder
0.09g, salmon powder 0.09g, powdered beef 0.09g, red date powder 0.09g;Peppermint 0.09g, Poria cocos 0.09g, matrimony vine 0.09g, wood
Melon 0.09g, Chinese yam 0.09g, mulberries 0.09g, spina date seed 0.09g, citron 0.07g;L-cn in natural plants compound
0.5g;Swan-mussel polysaccharide 0.01g in new resource food;Wherein, the weight of the water-soluble dietary fiber accounts for dietary fiber gross weight
70%~75%;The weight of the liposoluble vitamin accounts for the 10%~40% of vitamin gross weight;The protein is accounted for always
Energy 20~30%, fat accounts for the 10~25% of gross energy, carbohydrate and accounts for the 50~60% of gross energy.
Embodiment 4
The preparation method of hepatopathy tailored version clinical nutrition formula containing embodiment 1- embodiments 3 is as follows:
1) powdered oil (powder fat) is prepared:
A) the wall material aqueous solution is prepared:Take 10.5 grams of maltodextrin, 4 grams of soybean protein isolate, 11 grams of whole-fat milk powder, meals fine
2 grams of dimension (resistant dextrin), 0.5 gram of inulin, 5 grams of PURE WHEY, 0.5 gram of oligoisomaltose, 1 gram of soybean fiber, Arab
0.2 gram of glue, 50 milliliters of water stir and (have ready conditions and heat while stirring to 60 DEG C, room temperature is cooled to after being kept for 30 minutes).
B) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in (olive oil in 4.5 milliliters of greases monoglyceride
0.37 milliliter, it is 0.59 milliliter of soybean oil, 0.37 milliliter of coconut oil, 0.25 milliliter of perilla herb oil, 2.84 milliliters of medium chain triglyceride, single
0.08 milliliter of diglycerine fatty acid ester).
C) 0.1 gram (total solid concentration is 0.2%) is taken uniformly to be dissolved in the wall material aqueous solution Tween 80.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 0.1 gram (total solid concentration is 0.2%) to enter after mixed solution, is settled to water
Disperse 2 minutes at a high speed under 200 milliliters (total solid concentration is 25%), 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) obtained emulsion is spray-dried, EAT is 195 DEG C, leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, add weight be raw material weight 3~8 times of water, carry out immersion 3~4 hours, then to soak
Carry out decocting 30~60min, filtering removes raw material, leaves and takes decoction liquor, be spray-dried decoction liquor, with 60~80 mesh sieves point
Prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core, from carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing, the emulsifying homogeneous time is 10~15min, is then sprayed under high pressure as wall material
It is instantaneous to dry, prepare liposoluble vitamin powder with 60~80 mesh sieves point;Using the water soluble vitamin of predetermined weight number as
Core, from maltodextrin, lipoprotein as wall material, is well mixed, and spraying is instantaneous to be dried, and is prepared with 60~80 mesh sieves point water-soluble
Property vitamin powder;
4) by the protein of predetermined weight, carbohydrate, dietary fiber, macroelement, trace element, meals elite,
Natural plants compound and new resource food are prepared into the powder that particle diameter is 150~250 μm respectively;
5) by step 1)~step 4) obtained by powder sequentially add the mixers of cone-type mixer or other forms and mix
Uniformly obtained formula mixture is closed, it is standby after sterilization processing;
6) according to conventional technical means by step 5) in formula mixture be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral liquid.
In step 6) in, optionally increase appropriate food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, flavoring essence spices, brown sugar;More preferably carragheen, Arabic gum, Guar
Glue, Aspartame, flavoring essence spices.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent production
The danger of green powder blast.
Embodiment 5
The nutrient powder for taking the embodiment of the present invention 1~3 to prepare is tested, while setting comparative example 1, comparative example 2 and blank pair
According to group, comparative example 1 is using nutrient powder prepared by new resource food is deleted in the nutrient formulation of embodiment 2, comparative example 2 is using implementation
Nutrient powder prepared by integration of drinking and medicinal herbs composition, blank control group gavage physiological saline are deleted in the nutrient formulation of example 2.
1) the formula tailored version clinical nutrition that the present invention is provided is formulated the influence to mouse normal growth.
SPF grades of BALB/C mices, male and female half and half, body weight 25~30g, every group 10.Filled daily according to 0.2g/10g dosage
Stomach mouse, continuous 30 days.Single cage is fed during to mouse stomach, and it is determined daily and takes in appetite, claims 1 body weight within every 3 days, finally
Each group increased weight is calculated, 1 is shown in Table.
The hepatopathy tailored version clinical nutrition of table 1 is formulated the influence to mouse weight
Group | First body weight/g | Whole body weight/g | Weightening/g |
Embodiment 1 | 26.3 | 44.2 | 17.9 |
Embodiment 2 | 28.1 | 46.8 | 18.7 |
Embodiment 3 | 27.8 | 45.9 | 18.1 |
Comparative example 1 | 25.8 | 42.3 | 16.5 |
Comparative example 2 | 26.9 | 42.6 | 15.7 |
Control group | 27.4 | 41.6 | 14.2 |
Table 1 understands that the nutrient formulation has no to mouse weight growth and significantly affected, and can maintain the normal physiological work(of mouse
Can, harmful effect is not produced to the normal growth of mouse.
2) the formula tailored version clinical nutrition that the present invention is provided is formulated to CC14The influence of subacute hepatic injury mouse.
Cleaning grade SPF grades of male BALB/C mice 50,20~25g of body weight.Mouse using chow diet feed 1 week after with
Machine is divided into blank control group, CC14Model group and low dose group (20g/kg), middle dose group (40g/kg), high dose group (80g/
Kg), every group 10.The nutrient powder that wherein low dose group, middle dose group and high dose group are prepared using embodiment 2.
Normal group and CC1 during experiment4Model group is freely ingested drinking-water, basal feed normal supply;Three dosage
Group gives nutrient powder 20g/kg, 40g/kg, 80g/kg respectively daily, and feed nutrient powder gives basal feed, continuous 7 after terminating
Week, drinking-water of freely ingesting.
The induction of subacute liver injury model:In addition to blank control group, remaining four groups of animal abdominal cavity from testing the 1st day is noted
Penetrate 0.3% CC14Corn oil, dosage is 10ml/kg, is injected 2 times weekly, co-injection 3 weeks, sub- anxious with induced chemical
Property liver damage animal model.Final injection CC14Fasting 8 hours afterwards, retroorbital venous clump adopts hematometry serum glutamic pyruvic transminase
(ALT) and glutamic-oxalacetic transaminease (AST) level, evaluate whether liver injury model induces success.Liver injury model induces successful subsequent
It is continuous to give feeding by former scheme.After 7 weeks, each group mouse fasting 12 hours extracts eyeball blood sampling and prepares serum, determine ALT and
AST, its experimental result is as shown in table 2.
The nutrient formulation of table 2 is to CC14The influence of subacute hepatic injury mice serum liver enzyme activity.
As a result show, mouse is carried out after the induction 3 weeks of subacute liver injury model, with blank control group ratio, hepatic injury mould
Type group Serum ALT, AST activity are significantly raised, and the liver enzyme activity in each dosage group and model group ratio, serum has becoming for reduction
Gesture.Continue to mouse feeding to 7 weekends, model group Serum ALT, AST activity are still significantly higher than blank control group;With model group phase
Than each dosage group of feed nutrient powder then can significantly suppress CC14The rise of caused Serum ALT and AST, this shows this hair
Bright nutrient formulation is to CC14Subacute hepatic injury mouse has liver injury protection effect.
The specific embodiment of the present invention is described in detail above, but it is only used as example, and the present invention is not intended to limit
In particular embodiments described above.To those skilled in the art, it is any to the practicality carry out equivalent modifications and replace
In generation, is also all among scope of the invention.Therefore, the equalization made without departing from the spirit and scope of the invention is converted and repaiied
Change, all should be contained within the scope of the invention.
Claims (7)
1. a kind of hepatopathy tailored version clinical nutrition formula, it is characterised in that including following component:Protein, fat, carbon hydrate
Thing, dietary fiber, macroelement, trace element, vitamin, meals elite, integration of drinking and medicinal herbs composition, natural plants compound and
New resource food;
Wherein, the new resource food includes swan-mussel polysaccharide;
Wherein, the integration of drinking and medicinal herbs composition includes peppermint, Poria cocos, matrimony vine, pawpaw, Chinese yam, mulberries, spina date seed, citron.
2. a kind of hepatopathy tailored version clinical nutrition formula according to claim 1, it is characterised in that also thickened including food
Agent and food additives, the food thickening agent be guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar,
At least one of gelatin, Arabic gum, the food additives be Aspartame, flavoring essence spices, brown sugar at least
It is a kind of.
3. a kind of hepatopathy tailored version clinical nutrition formula according to claim 1, it is characterised in that the vitamin is water
Soluble vitamin and liposoluble vitamin, the weight of the liposoluble vitamin account for the 10%~40% of vitamin gross weight.
4. a kind of hepatopathy tailored version clinical nutrition formula according to claim 1, it is characterised in that the dietary fiber is
Water-soluble dietary fiber and insoluble dietary fiber, wherein the weight of the water-soluble dietary fiber accounts for dietary fiber gross weight
70%~75%.
5. a kind of hepatopathy tailored version clinical nutrition formula according to claim 1, it is characterised in that the weight of the component
Number is:20~30 parts of protein, 5~15 parts of fat, 45~55 parts of carbohydrate, 2~8 parts of dietary fiber, macroelement
0.6~1.2 part, 0.01-0.06 parts of trace element, 0.05~0.25 part of vitamin, 0.5~1.5 part of meals elite, integration of drinking and medicinal herbs
0.01-0.1 parts of 0.1~6 part of composition, 0.1-1 parts of natural plants compound and new resource food;Wherein described protein is accounted for always
Energy 20~30%, fat accounts for the 10~25% of gross energy, carbohydrate and accounts for the 50~60% of gross energy.
6. a kind of hepatopathy tailored version clinical nutrition formula according to claim 5, it is characterised in that the integration of drinking and medicinal herbs into
The parts by weight of each component are as follows in point:0~1 part of peppermint, 0~1 part of Poria cocos, 0~1 part of matrimony vine, 0~1 part of pawpaw, Chinese yam 0~1
Part, 0~1 part of mulberries, 0~1 part of spina date seed, 0~1 part of citron.
7. a kind of preparation method being formulated such as hepatopathy tailored version clinical nutrition according to any one of claims 1 to 6, its feature
It is, comprises the following steps:
Step 1: by the protein of predetermined weight number, fat, carbohydrate, dietary fiber, macroelement, trace element,
It is 150~250 μm that vitamin, integration of drinking and medicinal herbs composition, natural plants compound and new resource food are prepared into particle diameter respectively
Powder;
It is well mixed Step 2: powder prepared by the step one is poured into cone-type mixer successively;
Step 3: being prepared into nutrient powder, nutrition emulsion, capsule, tablet, ball using the powder being well mixed in the step 2
At least one of agent or oral liquid;
Wherein, the raw material of the integration of drinking and medicinal herbs composition is crushed, water extraction is concentrated, and concentrate progress spray drying is made into medicine
Eat homologous component powders;
Wherein, the vitamin and fat are handled by microencapsulation respectively is prepared into vitamin powder and fat powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710198915.1A CN106962912A (en) | 2017-03-29 | 2017-03-29 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710198915.1A CN106962912A (en) | 2017-03-29 | 2017-03-29 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106962912A true CN106962912A (en) | 2017-07-21 |
Family
ID=59337349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710198915.1A Pending CN106962912A (en) | 2017-03-29 | 2017-03-29 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106962912A (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107440103A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107510044A (en) * | 2017-09-09 | 2017-12-26 | 李绍波 | A kind of clinical liver disease nutrient formulation and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN108142877A (en) * | 2017-12-11 | 2018-06-12 | 千人计划创新药物与食品安全研究院扬州有限公司 | A kind of medical use hepatopathy full nutrition formula food and preparation method thereof |
CN108514109A (en) * | 2018-05-10 | 2018-09-11 | 上海奥医生物医药科技有限公司 | Anaesthetize postoperative tailored version clinical nutrition formula and preparation method thereof |
CN108618129A (en) * | 2018-05-10 | 2018-10-09 | 上海奥医生物医药科技有限公司 | Sarcopenia tailored version clinical nutrition formula and preparation method thereof |
CN108651988A (en) * | 2018-05-10 | 2018-10-16 | 上海奥医生物医药科技有限公司 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN108703364A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof |
CN109497514A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | AIDS tailored version clinical nutrition formula and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109497554A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of promotion lactation tailored version clinical nutrition composition and preparation method thereof |
CN109601977A (en) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | The food that suitable hepatopath eats |
CN114343172A (en) * | 2022-01-28 | 2022-04-15 | 特康药业集团有限公司 | Application of traditional Chinese medicine composition in food for improving liver function of chronic liver disease patient, nutrition powder and preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
-
2017
- 2017-03-29 CN CN201710198915.1A patent/CN106962912A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106490605A (en) * | 2016-12-23 | 2017-03-15 | 上海奥医生物医药科技有限公司 | A kind of hypertension of pregnancy tailored version clinical nutrition formula and preparation method thereof |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107373672A (en) * | 2017-08-23 | 2017-11-24 | 上海奥医生物医药科技有限公司 | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof |
CN107440103A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof |
CN107440102A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof |
CN107440121A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
CN107510044A (en) * | 2017-09-09 | 2017-12-26 | 李绍波 | A kind of clinical liver disease nutrient formulation and preparation method thereof |
CN108142877A (en) * | 2017-12-11 | 2018-06-12 | 千人计划创新药物与食品安全研究院扬州有限公司 | A kind of medical use hepatopathy full nutrition formula food and preparation method thereof |
CN108013453A (en) * | 2017-12-13 | 2018-05-11 | 上海奥医生物医药科技有限公司 | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof |
CN108095075A (en) * | 2017-12-13 | 2018-06-01 | 上海奥医生物医药科技有限公司 | Miscarriage women tailored version clinical nutrition formula and preparation method thereof |
CN107927754A (en) * | 2017-12-13 | 2018-04-20 | 上海奥医生物医药科技有限公司 | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production |
CN108703365A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
CN108618129A (en) * | 2018-05-10 | 2018-10-09 | 上海奥医生物医药科技有限公司 | Sarcopenia tailored version clinical nutrition formula and preparation method thereof |
CN108651988A (en) * | 2018-05-10 | 2018-10-16 | 上海奥医生物医药科技有限公司 | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof |
CN108514109A (en) * | 2018-05-10 | 2018-09-11 | 上海奥医生物医药科技有限公司 | Anaesthetize postoperative tailored version clinical nutrition formula and preparation method thereof |
CN108703364A (en) * | 2018-05-10 | 2018-10-26 | 上海奥医生物医药科技有限公司 | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof |
CN109601977A (en) * | 2018-08-07 | 2019-04-12 | 丽睿客信息科技(北京)有限公司 | The food that suitable hepatopath eats |
CN109497514A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | AIDS tailored version clinical nutrition formula and preparation method thereof |
CN109497563A (en) * | 2018-10-23 | 2019-03-22 | 上海奥医生物医药科技有限公司 | Leucoderma tailored version clinical nutrition formula and preparation method thereof |
CN109497554A (en) * | 2018-11-15 | 2019-03-22 | 上海奥医生物医药科技有限公司 | A kind of promotion lactation tailored version clinical nutrition composition and preparation method thereof |
CN114343172A (en) * | 2022-01-28 | 2022-04-15 | 特康药业集团有限公司 | Application of traditional Chinese medicine composition in food for improving liver function of chronic liver disease patient, nutrition powder and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN107242550A (en) | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN107319524A (en) | A kind of nephrosis tailored version clinical nutrition formula and preparation method thereof | |
CN109645320A (en) | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof | |
CN106983151A (en) | A kind of inflammatory bowel disease tailored version clinical nutrition formula and preparation method thereof | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
KR101738912B1 (en) | Composition For Anti-obesity And Diet | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN102573523A (en) | Health supplement food, feed, and pharmaceutical composition comprising chia seed and maca, and manufacturing method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN107440102A (en) | A kind of climacteric women tailored version clinical nutrition formula and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108669540A (en) | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof | |
CN108618126A (en) | A kind of Chinese medicine compound prescription weight-reducing special diet food and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN110547470A (en) | A nutritional composition for improving male sexual function, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170721 |